BioSpace News Archive

Increasing prevalence various chronic diseases, rising adoption of cloud-based applications, and high focus on reducing costs of drug discovery and development are expected to drive global Intelligent Drug Discovery market growth.

Increasing incidence of various types of cancer worldwide, growing demand for radiation therapy for cancer diagnosis and treatments, and rapid advancements in radiation technology are some key factors expected to drive global Medical Radiation Detection, Monitoring, and Safety market growth.

Increasing prevalence of various types of cancers worldwide, ongoing research on cancer, growing demand for precision medicine, and rapid adoption of advanced technologies in the healthcare sector are some key factors expected to drive global Oncology Informatics market growth.

Increasing prevalence of chronic diseases and infectious conditions across the globe, growing awareness about tissue imaging, and rising investments in research and development activities are some key factors expected to drive global Tissue Imaging market growth.

According to Nova one advisor, during the forecast period of 2022 to 2030, the global ACL Reconstruction Procedures market is estimated to develop at a strong growth rate.

ValnevaSE, a specialty vaccine company, announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Jefferies Healthcare Conference which will take place from June 8 to 10, 2022 in New York.

Santhera Pharmaceuticals has updated its corporate calendar. The Company will publish its 2021 AnnualReport onJune 10, 2022 andhold its Annual General Meeting on June 30, 2022.

ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, is pleased to announce sponsorship of an American Diabetes Association Thought Leadership Video on Podocyte Lipotoxicity, a Cause of Diabetic Kidney Disease and Its Progression.

The global Acute Agitation And Aggression Treatment market is estimated to develop at a compound annual growth rate (CAGR) of 6.4%.

The global Adrenocorticotropic Hormone [ACTH] market is estimated to develop at a compound annual growth rate (CAGR) of 3.7%.